Established in the 1970s, Iogen Corporation has become one of Canada's leading biotechnology firms. Iogen is an industrial manufacturer of enzyme products with a focus on products for use by the pulp and paper, textile and animal feed industries. It also is the world leader in technology to produce cellulose ethanol, a fully renewable, advanced biofuel that can be used in today's cars.
Iogen is a privately held company, based in Ottawa, Ontario, Canada, with a rapidly growing work force. Public and private investment in Iogen has totaled approximately $130 million over the past 25 years. Major investors include the Royal Dutch/Shell Group, Petro-Canada and the Government of Canada. Iogen employs a staff of approximately 180 people, with over half involved in research and development, and engineering; one fifth in manufacturing; and the balance in sales, marketing, and administration.
Cellulose Ethanol is Ready to Go
Cellulose ethanol can significantly:
lower overall greenhouse gas (GHG) emissions
reduce reliance on imported oil and increase energy security
help build rural economies and improve farm income
Cellulose ethanol is one of the most cost effective ways to reduce GHGs and gasoline consumption in road transport and can deliver benefits similar to improved vehicle efficiency.
Iogen built and operates the world's only demonstration scale facility to convert biomass to cellulose ethanol using enzyme technology. This facility is located in Ottawa. Iogen is currently assessing potential locations for the world's first commercial prototype cellulose ethanol plant.
In the long-term, Iogen intends to commercialize its cellulose ethanol process by licensing its technology broadly through turnkey plant construction partnerships. License fees and the supply of enzymes to the licensees' plants will generate income.
| Contact Details: |
| 310 Hunt Club Rd. East |
| Ottawa |
| Ontario |
| K1V 1C1 |
| Canada |
| Tel: | 613-733-9830 |
| Fax: | 613-733-0781 |
| Email: | info@Iogen.ca |
| WWW: | www.iogen.ca/
|
|
Loading...
|
Recent Publications by Iogen: |  |
Introduction to session 4.
The regulation of gene expression by the tetracycline system has attracted... | 26th June, 2008
| Iogen Corp., Oftowa, Ontario, Canada.
| Appl Biochem Biotechnol. 1998 Spring;70-72:805-6.
DOI Direct Link |
The small domain of cytochrome f from the psychrophile Chlamydomonas raudensis UWO 241 modulates the apparent molecular mass and decreases the accumulation of cytochrome f in the mesophile Chlamydomonas reinhardtii.
Cytochrome f from the psychrophile Chlamydomonas raudensis UWO 241 has a... | 16th January, 2008
| Department of Biology and The Biotron, University of Western Ontario,
| Biochem Cell Biol. 2007 Oct;85(5):616-27.
DOI Direct Link |
Systems biology of AGC kinases in fungi.
Sch9 appears to be the Saccharomyces cerevisiae homolog of protein kinase... | 13th October, 2006
| Iogen Corporation, 310 Hunt Club Road East, Ottawa, Ontario, K1V 1C1,
| Sci STKE. 2006 Sep 12;2006(352):re9.
DOI Direct Link |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 160 times since April 2007, the link to the organisation's website has been followed 21 times
Recent Search Terms used to find this page: iogen public 2008 | iogen patents | .
Search for more companies in Ottawa
Search for more companies in Ontario
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Iogen
